Percentage of donor organs recovered for transplant in the U.S. with machine perfusion intended or performed by donation quarter and organ
Lung perfusion has more than tripled since 2015, growing from 1.7 percent to 6.3 percent and potentially expanding the pool of organs available for transplant.
The proportion of livers being treated with this transformative technology (including normothermic, hypothermic and other perfusion), also showed similar steady growth, jumping from just .1 percent in 2016 to 1.4 percent by the end of 2018. The OPTN began collecting data (from the Deceased Donor Registration) on the percentage of donor organs intended for ex vivo normothermic machine perfusion (NMP) and their location four years ago.
Read about the potential impact of NMP on transplantation and meet the companies leading the way in its development.
Number of donor organs (heart, liver, and lung) recovered for transplant in the U.S. with machine perfusion intended or performed
Center Acceptance and Refusal Evaluation (CARE) Report allows transplant centers to see all of the offers they accept as well as all those they refuse.
Research shows family patterns affecting risk can predict whether a living donor will develop end-stage renal disease decades after donating a kidney to a related recipient.
Through focused quality improvement and education practices, LifeLink of Georgia has almost tripled recovery of African-American donors.